Goldman Sachs Removes Clorox (CLX) from its Conviction Buy List
More News related to CLX
- The Stain Doctor Is In With 24/7 Holiday Clean-Up Prescriptions
- Clorox (CLX) Declares $0.50 Quarterly Dividend; 3.3% Yield
- Clorox Declares Regular Quarterly Dividend
- Clorox Announces Pricing of $300 Million Senior Notes
- The Clorox Company Joins the Business Coalition for Workplace Fairness
More News related to Analyst Comments
- Interesting Call Buying In Research In Motion (RIMM)
- Broadpoint.AmTech Reiterates a 'Buy' on Marvell Technology (MRVL); Raises Estimates & PT
- Unemployment Data Brings Hope: Art Hogan Weighs In
- Brean Murray Maintains a 'Buy' on athenahealth (ATHN); Lofty Valuation Surpassed Only by Lofty Goals
- Benchmark Raises American Tower's (AMT) Price Target to $50 on Strong Tower Demand
Goldman Sachs removes Clorox Corporation (NYSE: CLX) from its Conviction Buy List. The firm has a Buy rating and $63 price target on CLX.
The Clorox Company manufactures and markets a range of consumer products.
Related Categories
Analyst CommentsStocks Mentioned
+0.27Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
